Eastman Chemical enters the second half of 2026 with a sharper operating story than the headline numbers suggest. Second quarter sales of $2,513M rose 10% year over year, but the more interesting data point sits inside the segment table: Chemical Intermediates revenue jumped 39% on tighter industry supply stemming from the ongoing Middle East conflict, and the segment swung from a $30M operating loss in the prior-year quarter to a $58M profit. Adjusted EBIT of $320M rose 16% and adjusted diluted EPS of $1.97 climbed 23%, demonstrating that price-cost recovery in the commodity chain is finally arriving.
The contradiction at the heart of the print is that consolidated earnings are being held back by a separate destocking cycle in Fibers, where acetate tow volumes declined for the second consecutive quarter. Adjusted EBIT in Fibers fell 56% to $36M, and Advanced Materials slipped 10% on lower utilization at European performance films. These are not company-specific failures; they are inventory corrections and one-time plant closures that should resolve in 2027.
The investment case rests on whether the intermediate chemicals upcycle, the molecular recycling platform, and the disciplined capital allocation can offset the structural decline in textiles-tied Fibers. Management deployed $600M of new 4.5% notes in the first quarter to refinance near-term maturities, leaving $691M in cash and an undrawn $1.50B revolver. Net debt of $4.5B against roughly $1.5B of expected annual EBITDA gives the company meaningful balance sheet capacity to fund both the $1.3B remaining buyback authorization and the Kingsport molecular recycling expansion.